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Background: The development of novel antischistosomal drugs is crucial, as currently no vaccine and only a single
drug is available for the treatment of schistosomiasis. Fast and accurate in vitro assays are urgently needed to
identify new drug candidates and research efforts should include Schistosoma haematobium. The aim of the
present study was to develop a S. haematobium drug sensitivity assay based on newly transformed schistosomula
(NTS).
Methods: We first undertook comparative studies on the cercarial emergence rhythms of the intermediate host
snails Biomphalaria glabrata (S. mansoni) and Bulinus truncatus (S. haematobium). Two transformation methods as
well as three purification methods were studied on S. haematobium cercariae in order to produce a large number
of viable and clean NTS. Known antischistosomal drugs were tested in the established NTS assay in vitro. Drug
effects were evaluated either microscopically or fluorometrically, using a resazurin based viability marker.
Microscopically obtained IC50 values were compared with results obtained for S. mansoni.
Results: A circadian rhythm existed in both snail species. Infected B. truncatus snails shed less cercariae than
B. glabrata during the testing period. The highest transformation rate (69%) of S. haematobium cercariae into NTS
was obtained with the vortex transformation (mechanical input) and the highest purification factor was observed
using PercollW. The fluorimetric readout based on resazurin was very precise in detecting dead or/and severely
damaged schistosomula.
Conclusions: With the use of viability markers such as resazurin, drug screening assays using S. haematobium NTS
can be efficiently performed. However, drugs acting on the morphology and motility of S. haematobium NTS, such
as metrifonate are missed. Drug sensitivity assays with NTS of both species, S. haematobium and S. mansoni,
showed very similar results using known antischistosomal drugs. The S. mansoni NTS assay might be more suitable
as primary screen in drug discovery efforts, which ultimately aim for a broad-spectrum antischistosomal drug as a
larger number of S. mansoni NTS can be generated.
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Schistosomiasis remains one of the most prevalent hel-
minthic infections in the world. Human schistosomiasis
is caused by three main species including Schistosoma
haematobium and Schistosoma mansoni. Schistosomes
have a complex life cycle with snails serving as the inter-
mediary host between the mammalian hosts. Approxi-
mately 800 million people are at risk of schistosomiasis* Correspondence: jennifer.keiser@unibas.ch
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reproduction in any medium, provided the orin 74 developing countries, with an estimated 200 mil-
lion people currently infected. Schistosomiasis is a
neglected tropical disease, however, just ranks below
malaria in terms of its public health importance [1-4].
Control of schistosomiasis relies on preventive chemo-
therapy programs targeting the entire at risk population
[5]. Up to now, praziquantel has been the drug of choice
[6-8]. The drug is safe, has a broad therapeutic profile,
and is cheap. However, these advantages have impeded
the advances in the development of new drug candidates
and vaccines [8,9]. In addition, praziquantel is not aLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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worms, leading to a decreased ability of praziquantel to
completely clear infections [8,9]. In addition, with the
threat of drug resistance that accompanies preventive
chemotherapy programs it is imperative to develop a
novel antischistosomal drug. This drug should have a
broad spectrum of trematocidal activity, similar to prazi-
quantel. Given the known biological differences between
S. mansoni and S. haematobium, drug screening should
include testing against S. haematobium.
In the past years efforts have been made to improve
drug sensitivity in vitro assays with S. mansoni enabling
the testing of a larger number of compounds and
improved readouts such as those with Alamar BlueW
(a resazurin based viability marker) [10]. However, to
our knowledge drug screening assays with S. haemato-
bium continue to rely mainly on the adult worm.
The aim of the present work was to develop and valid-
ate an in vitro drug screening assay for S. haematobium
newly transformed schistosomula (NTS). In a first step
the cercarial emergence rhythms of the intermediate
hosts of S. mansoni and S. haematobium, Biomphalaria
glabrata and Bulinus truncatus were studied. Next, two
artificial transformation methods for the production of
the schistosomula were compared. In addition, the best
purification method and optimal culture conditions were
established by testing three different methods and sev-
eral different media [11-14]. Finally, an assay based on
the viability marker resazurin, which is the active com-
ponent of Alamar BlueW and a redox indicator of en-
zyme activity, using selected compounds of known
antischistosomal activity such as praziquantel, meflo-
quine, artesunate, metrifonate, and oxamniquine was
established and the results compared to a standard mo-
tility assay using microscopical readout. Results were
compared with drug activity observed microscopically
against S. mansoni NTS.
Methods
Drugs and media
Praziquantel (Sigma Aldrich), mefloquine (kindly pro-
vided by Mepha Pharma AG, Switzerland), artesunate
(kindly provided by Mepha Pharma AG, Switzerland),
metrifonate (kindly provided by Bayer Animal Health,
Germany), and oxamniquine (kindly provided by Q.
Bickle, London School of Hygiene and Tropical Medi-
cine) were used as antischistosomal compounds. Drugs
were dissolved in dimethylsulphoxide (DMSO) (Sigma
Aldrich) to obtain drug stock solutions of 10 mg/ml and
then diluted into culture media. A resazurin solution
was prepared by dissolving 12.5 mg resazurin (Sigma
Aldrich) in 100 ml of 1x PBS. Different media such as
Basch Medium 169 (prepared in our laboratories),
Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco)and Medium 199 (Invitrogen, Carlsbad, CA) were tested
and compared to obtain optimal culture conditions for
the S. haematobium NTS. All test media were supple-
mented with 5% heat-inactivated fetal calf serum (FCS)
based on the culture media protocol of Bash 1981 [12]
and 200 U/ml penicillin and 200 μg/ml streptomycin
(Sigma Aldrich).
Snails and schistosomes
Bulinus truncatus infected with S. haematobium were
obtained from BEI Resources, NIAID (NIH: Schistosoma
haematobium exposed Bulinus truncatus subsp. trunca-
tus, NR-21965). S. mansoni infected B. glabrata are
maintained at the Swiss Tropical and Public Health In-
stitute in Basel. The snails had been individually infected
with either 10 miracidiae per snail (B. truncatus) or 8
miracidiae per snail (B. glabrata). Snails were kept in
tanks with dechlorinated tap water in a humid room
simulating a 12 hour day and night cycle. First shedding
of cercariae occurred 4–6 weeks post infection. Both
snail species were then collected in the morning (Size of
snails: 6 – 11 mm, number of collected snails: approxi-
mately 70–90 of each species) and placed individually
into 24 or 48 well plates (1 ml dechlorinated tap water/
well). Each well plate was placed under a direct 2000 lux
lamp for at least 5 hours. The cercarial suspension of
each B. glabrata/B. truncatus was collected and used for
the mechanical and chemical transformation. For the
cercarial emergence rhythm studies, B. glabrata/B.
truncatus were collected (n = 90) in the morning at 8 am
and put, as described above, in dechlorinated water filled
well plates (1 ml/well) until 3 pm. During this period the
cercariae suspension of each snail was collected hourly
and counted for each snail under a light microscope.
The hourly collected cercariae suspension was replaced
with dechlorinated tap water.
Vortex transformation
The vortex transformation was performed based on a
slightly adapted protocol of Ramalho-Pinto [11]. Briefly,
a cercarial suspension was placed on ice for 30–40 min-
utes in order to reduce parasite motility. Tubes were
then centrifuged for 3 minutes at 3000 rpm. The cercar-
ial pellet was resuspended in 2 ml cold Hanks` Balanced
Salt Solution (HBSS) containing 2% amphotericin B
(Sigma Aldrich). The suspension was vigorously mixed
through a pipette followed by 4 minutes vortexing in
order to induce tail shedding.
This step was repeated after an incubation of the
mixed tail-schistosomula suspension for 20 minutes at
37°C. The transformation rate was calculated by count-
ing the total number of cercariae in the HBSS suspen-
sion before transformation, and placing them in relation
to the total number of schistosomula obtained after
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five identically performed mechanical transformations.Glucose induced transformation
The chemical transformation was carried out as described
previously [11]. The cercariae suspension was cooled on
ice for 30 minutes to reduce parasite motility. After 2 min-
utes of centrifuging at 2000 rpm, the cercariae suspension
was resuspended in 4 ml of 5% glucose and incubated for
10 minutes in a 30°C waterbath. The tails were removed
from the bodies using the ice purification method (see
next paragraph). The transformation rate was calculated
as described above and was calculated for five identically
performed chemical transformations.Purification and culture of schistosomula
The separation of the bodies from the tails by centrifu-
gation on a 70% PercollW gradient (polyvinylpyrolidone-
coated colloidal silica particles) was based on the
method of Lazdins et al. [13]. 71.7 ml of PercollW (Sigma
Aldrich, starting density 1.13 g/ml) was diluted directly
in 10 ml 1.5 M NaCl and filled up to 100 ml with dis-
tilled H2O to obtain a final working solution. 10 ml of
the working PercollW solution was layered on the bottom
of a 50 ml Falcon tube. The gradient was topped by
carefully adding 5 ml of the transformed schistosomula
suspension. The tube was then centrifuged for 10 min-
utes at 2000 rpm and 5°C. After centrifugation, 5 ml of
the sample was collected from the bottom of the tube
after perforation using a heated 16-gauge needle. The
collected fraction was then diluted in 7 ml of Medium
199 and centrifuged for another 3 minutes at 3000 rpm.
The schistosomula pellet was resuspended in 1 ml of
fresh, warm supplemented Medium 199.
Another purification method of the schistosomula was
based on a simple and easy swirling technique according
to F. Lewis et al. [14]. The schistosomula suspension
was placed on a Petri dish and sufficient warm Me-
dium 199 added so that the bottom of the Petri dish
was completely covered. By swirling the dish gently, all
schistosomula accumulated in the center and could be
transferred into Falcon tubes. The swirling and collect-
ing step was repeated until schistosomules were no
longer present in the center of the dish (approximately
4–5 times).
In addition, the ice method was tested for purification.
7 ml of cold HBSS was added to the schistosomula sus-
pension and cooled on ice for 7 minutes. The super-
natant was decanted, and the pellet resuspended again
in 7 ml of cold HBSS. This step was repeated three
times. The pellet that contained the recovered schistoso-
mula was then resuspended in preheated (37°C) supple-
mented Medium 199.After the experiment the number of heads and tails
were counted using a sample of 50 μl. The ratio was
expressed as purification factor. Every method was per-
formed three times identically and the mean purification
factor was calculated.
After successfully transforming cercariae into schisto-
somula and purifying them, the NTS were incubated for
at least 12 hours in supplemented Medium 199 at an at-
mosphere of 37°C with 5% CO2 until usage to assure
complete transformation [10].
Different media, namely supplemented Basch Medium
169, Dulbecco’s Modified Eagle’s Medium and Medium
199 were tested and compared to obtain optimal culture
conditions for the S. haematobium NTS. Viability of
NTS (150–200 per media) was assessed based on their
morphology and motility using a viability scale ranging
from 3 (normal activity, no morphological changes) to 0
(dead), as described previously using increments of 0.5
[15].
In vitro S. haematobium drug assay with microscopical or
fluorimetric readout
NTS were obtained by mechanical transformation of
S. haematobium cercariae as described above. The schis-
tosomula suspension was adjusted to a concentration of
2 NTS per μL with supplemented Medium 199. A 3-fold
serial dilution was next performed vertically down a flat
bottom 96-well plate, to obtain final drug concentrations
of 1.1, 3.3, 10, 30, 90 μg/ml after adding 50 μl of the
adjusted NTS suspension yielding a final volume of
250 μl per well [16]. Each drug concentration was tested
in duplicate and performed at least three times. Live and
dead schistosomula (treated with 70% ethanol) served as
a positive and negative control.
For the microscopical readout, assays were evaluated
under an inverted bright-field light microscope (Carl
Zeiss AG, 8 x 10 magnification) 24, 48 and 72 hours post
drug exposure.
NTS were evaluated using the viability scale as
described above. IC50 values were calculated using Com-
puSyn software (Version 3.0.1, 2007; ComboSyn, Inc).
Furthermore, drug effects were determined with the
help of resazurin, a fluorimetric marker for cell viability
[17]. Assays were conducted as described above with the
exception that 48 hours post drug exposure 20 μl of the
prepared resazurin solution was added to each well.
Background fluorescence and absorbance of the drug
containing medium were determined for each drug dilu-
tion. Wells without drug served as controls. After an-
other 24 hours of incubation, fluorescence development
was determined (after a total drug incubation time of
72 hours). Fluorescence was measured using a Spectra-
max M2 plate reader (Molecular Devices) at 530 nm ex-
citation wavelength and 590 nm emission wavelength.
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fluorescence detection using the Softmax Pro Program
(Molecular Devices).
In vitro S. mansoni drug assay with microscopical readout
NTS from S. mansoni were obtained with the same vor-
tex transformation procedure as mentioned above. The
ice purification method was sufficient to separate the
bodies from the tails. A lower antibiotic dose (1%
penicillin-streptomycin mix) was used for the assays, as
lower contamination occurred here. Evaluation was done
microscopically using the same viability scale (0–3) as
mentioned before.
Statistical analysis
Arithmetic Means and standard deviation were calcu-
lated using Microsoft ExcelW software for cercarial shed-
ding patterns, transformation and purification factors,
fluorescent signals and evaluated IC50 values. All values
were tested for normality. Student’s one-sample t-test
was used to analyze the statistical significance of differ-
ences between mean experimental and control values of
the fluorescent values for each NTS drug assay. A
P-value of < 0.05 was considered significant.
Results
Cercarial emergence rhythm
The cercarial shedding of the two snail species B.
truncatus and B. glabrata followed a clear circadian
rhythm, after a simulated 12:12 hour light dark cycle in
the laboratory. There was one shedding peak a day
which slightly differed in time and intensity according to
the species (Figure 1). The daily emergence pattern peak
for B. glabrata occurred between 11 am and 1 pm,
whereas for B. truncatus the peak occurred a little earlier
between 10 am and 11.30 am. The total number ofFigure 1 Circadian rhythm of cercariae released from S. haematobium
Mean values of (n = 3) performed experiments are shown, bars indicate stacercariae shed was 2.7-fold higher for S. mansoni
infected Biomphalaria snails than for S. haematobium
infected Bulinus snails.
Transformation and purification
The highest transformation rate (mean of 69%) was
observed for the vortex transformation. The previously
described protocol for the vortex transformation [11] had
to be slightly modified, such as increasing the number of
pipetting (40x), increasing the vortex time (4 minutes) and
using HBSS medium supplemented with 2% amphotericin
B in order to achieve a continuously high transformation
rate. Since high transformation rates were achieved with
supplemented HBSS no other media were tested during
the transformation procedure. A transformation rate of
only 34% (mean value) was obtained with the chemical
transformation. Both transformation methods were easy
to perform.
In order to obtain the best method for purifying the
NTS from the tails shed after transformation, a purifica-
tion factor was calculated for three purification methods
(PercollW, ice and swirling method). The best purifica-
tion factor was observed for PercollW with 24.4 ± 11.4,
followed by the swirling method with 11.7 ± 3.2 and the
ice method presenting a mean purification factor of
3 ± 1.7.
Optimal culture conditions for S. haematobium
schistosomula
All media for S. haematobium were supplemented with
200 U/ml penicillin and 200 μg/ml streptomycin. This
was the ideal concentration of antibiotics to get rid of
bacterial contamination that occurred from B. truncatus
snail excrement, which could not be eliminated during
sedimentation in the first vortex transformation steps.
Supplemented Medium 199 turned out to be the mostinfected B. truncatus and S. mansoni infected B. glabrata snails.
ndard deviations.
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obtained by transformation in supplemented HBSS. The
parasites remained viable for 120 h with an average via-
bility value of 2.5. On the other hand, all schistosomula
had died by 72 hours in Basch medium and by 144 hours
in DMEM (Figure 2).
Evaluation of resazurin as potential fluorimetric marker
for the S. haematobium NTS in vitro assay
In an initial experiment the relationship between the
fluorescence signal of the converted resazurin and schis-
tosomula numbers (0–250 NTS tested) was studied. A
linear relationship (R² = 0.95) between fluorescence de-
velopment and NTS number was observed within a
range of 25–200 NTS per well, as depicted in Figure 3.
No increase in the fluorescence signal was observed
using 250 schistosomula per well and above. Dead schis-
tosomula and medium did not show any significant
background signals.
In vitro S. haematobium NTS drug assay using
microscopical readout compared with fluorimetric
readout
As seen in Table 1, mefloquine showed the highest activ-
ity (IC50 value of 0.5 μM) followed by artesunate
(1.4 μM), praziquantel (1.5 μM) and metrifonate
(1.6 μM) against S. haematobium NTS using microscop-
ical readout. For oxamniquine only low to moderate
antischistosomal effects were observed against the schis-
tosomular stage (IC50: 26.5 μM). Severe effects on the
morphology of S. haematobium NTS were observed 24,
48 and 72 hours post exposure with praziquantel, meflo-
quine and artesunate. Concentrations of 90 μg/ml prazi-
quantel and mefloquine killed the parasite within 48 and
24 hours, respectively. Both drugs caused strong mor-
phological changes such as severe deformation and
increased granularity. Metrifonate killed all the parasites,
after 24 hours drug exposure with 90 μg/ml and afterFigure 2 Survival time of S. haematobium NTS (150–200 NTS per well72 hours at a concentration of 30 μg/ml. At lower con-
centrations such as 1.1 μg/ml, 3.3 μg/ml and 10 μg/ml,
motility was reduced until hardly any movement could
be observed after 48 and 72 hours. Oxamniquine treat-
ment caused only slight morphological changes such as
rounding but resulted in strongly reduced motility.
In a next step, IC50 values were determined in this
assay using resazurin as viability marker. Praziquantel
revealed the highest activity with an IC50 below 3.5 μM
(P< 0.05) (Table 1). Mefloquine (6.4 μM) and artesunate
(7.4 μM) showed similar promising activities whereas
oxamniquine (>322.2 μM) and metrifonate (348.3 μM)
were characterized by a low activity in this assay (all
P < 0.05).
The IC50 values obtained for praziquantel, mefloquine
and artesunate against S. haematobium NTS pre-
sented within similar ranges when evaluated micro-
scopically or fluorimetrically. Oxamniquine lacked an
antischistosomal effect according to the fluorimetric
readout (IC50 > 322.2 μM) while a moderate activity
was observed when the effects of the drug were assessed
microscopically (26.5 μM). To note, great differences
were also observed between the readouts for metrifonate
(348.3 μM versus 1.6 μM).
Comparison of IC50 values of S. haematobium and
S. mansoni NTS
Using microscopy, very similar IC50 values of the 5
standard drugs were calculated for S. haematobium and
S. mansoni NTS (Table 1).
Discussion
S. haematobium is a neglected parasite that still affects
several million people per annum [1-4]. There is cur-
rently one drug available as the core treatment of schis-
tosomiasis and it is worrying that low cure rates with
praziquantel have already been reported in several en-
demic countries for S. mansoni [18]. To our knowledge,) in different culture media.
Figure 3 Relationship between fluorescence signal and number of schistosomula (25–250 schistosomula per well) in the resazurin
based assay. Figure shows an average curve of four replicates, bars indicate standard deviations of the performed experiments. Fluorescence
was measured after 24 hours of incubation. The fluorescence decreased with schistosomula concentrations above 200 per well. Linear regression
is shown for data of 25-200 NTS.
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sensitivity assay using S. haematobium NTS and add-
itionally evaluated resazurin as a viability marker in this
assay.
We first focused on the intermediate host snails and
observed that the cercarial emergence rhythm of B.
glabrata infected with S. mansoni as well as B. truncatus
with S. haematobium showed one distinct peak for each
species. It is important to state that these observations
are based on long term laboratory isolates and the cer-
carial output of the imported Bulinus snails could also
be influenced by the transportation between laboratoriesTable 1 Comparison of the IC50 values of tested drugs for
S. haematobium and S. mansoni schistosomula at the
72 hours time point evaluated microscopically and for S.
haematobium NTS additionally fluorimetrically with
resazurin
Technique Drug IC 50 values (μM) (mean± SD)
S. haematobium S. mansoni
Microscopy Praziquantel 1.5 ± 1.1 0.7 ± 0.1
Mefloquine 0.5 ± 0.2 0.7 ± 0.1
Artesunate 1.4 ± 0.1 1.5 ± 0.6
Metrifonate 1.6 ± 0.0 0.8 ± 0.1
Oxamniquine 26.5 ± 3.4 11.8 ±0.0
Resazurin Praziquantel <3.5 ND
Mefloquine 6.4 ND
Artesunate 7.4 ND
Metrifonate 348.3 ND
Oxamniquine >322.2 ND
IC50 values are calculated from three replicates at a concentration range of
1.1-90 μg/ml. ND: Not determined.(~3 days of transport). However, the daily emergence
pattern peak for B. glabrata occurred between 11 am
and 1 pm, whereas for B. truncatus the peak occurred a
little earlier between 10 am and 11.30 am. These results
underline the fact that infected B. glabrata and B.
truncatus snails show a distinct cercarial chronobiology
[19,20]. It has been shown that B. glabrata shed approxi-
mately 2.7 times the number of cercariae per day (mean
of 446 cercariae per snail) compared to B. truncatus
(mean of 160 cercariae per snail), despite B. truncatus
being exposed to a greater number of miracidia (10 per
snail) than B. glabrata (8 per snail). We did not observe
any influence of size or appearance of the snails such as
calcareous deposit (calcification strips on the snail’s
shell) on the daily cercarial shedding in B. truncatus
snails. Surprisingly, these findings contradict a previous
report [21] that had shown that cercarial output is
related to the size of snail, meaning larger snails
(9–10 mm diameter) shed much more cercariae than
smaller sized snails (5–6 mm).
The mechanical transformation as described by
Ramalho-Pinto et al. for S. mansoni was successfully
tested on S. haematobium and yielded a transformation
rate of 69% [11]. Overall both transformation methods,
mechanical and chemical turned out to be very applic-
able on S. haematobium cercariae and were simple to
perform. It is interesting to note that the chemical
stimulation had a much lower transformation rate
(30–41%) than the mechanical stimulation (59–87%).
Salafsky et al. [22] reported that chemically transformed
cercariae lost their osmoregulation ability at a much
higher rate than during any other transformation
method. Furthermore, Ramalho-Pinto et al. [11]
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sensitivity as compared to fully intact cercariae. These
findings might explain the reason for the lower trans-
formation rate in chemical stimulation.
We made the observation that increasing the time of
vortexing resulted in decreased fitness of the parasites
over time (data not shown). For this reason, we did not
further increase the vortex time. We also did not use the
syringe method, which might be worthwhile testing in fu-
ture studies to achieve even higher transformation rates.
After successfully transforming cercariae, schistoso-
mula had to be purified from the tails shed and fully in-
tact cercariae. Unfortunately, the ice method described
by Fred Lewis [14] turned out to be less successful with
S. haematobium and thus two other purification meth-
ods were tested, namely the swirling method and
PercollW method, which were previously described in
the literature [13,14]. Both of these methods successfully
separated tails from the schistosomula. PercollW turned
out to be twice as effective as the swirling method. The
silica colloid gradient was non-toxic and did not affect
any assay procedures [13]. Schistosomula isolated by
centrifugation on PercollW did not show any loss in via-
bility, as evaluated by morphological examination. How-
ever, it must be emphasized that using PercollW for the
purification is an expensive method compared to the
swirling method. Nevertheless, taking all advantages of
the gradient together, PercollW was used for all further
transformation and purification experiments performed.
Drug sensitivity screenings were performed on newly
transformed S. haematobium schistosomula, derived
from successful vortex transformations, first with the
classical microscopical readout. Note that, the assess-
ment of the parasite viability microscopically in vitro is
based on two parameters: regular or lack of movement
of larvae (motility) and morphological changes such as
granularity and shape alterations [22]. However, micro-
scopic assessment is subjective, slow, labor intensive and
requires experience [23,24]. For this reason, it is crucial
to find other evaluation and screening methods based
not only on microscopic examination. In our study the
widely used viability indicator resazurin, the active com-
ponent of Alamar BlueW, was evaluated.
In our preliminary studies it could be shown that a lin-
ear correlation exists between the fluorescence signal
and viable transformed schistosomula. Fluorescence
values per well increased proportionally to the number
of schistosomula up to the amount of 200 schistosomula.
The use of more than 200 schistosomula resulted in
decreased fluorescence values. This might be due to
crowding effects in the well.
A correlation is observed between microscopic and
fluorometric readout treating S. haematobium with arte-
sunate, praziquantel and mefloquine. All three drugsshowed clear dose response relationships (decrease in
viability with increasing concentrations) in both the
microscopic and fluorometric readout. However, the
determined IC50 values in the resazurin based assay pre-
sented a slightly higher range compared to values calcu-
lated based on microscopy. This indicates that the
sensitivity of resazurin as an indicator of metabolic activ-
ity, shows a higher sensitivity on the detection of viabil-
ity than the motility observations via the microscope.
Furthermore, it is important to mention that in particu-
lar for the microscopic results for several of the tested
drugs, the lowest concentrations tested were in the
range of the calculated IC50 values (e.g. mefloquine), and
lower concentrations were not tested in the present
work resulting in extrapolated IC50 values. On the other
hand, important morphological criteria are taken into
account within the microscopic approach, which might
be missed using fluorimetric viability markers. Interest-
ingly, the fluorometric readout regarding oxamniquine
and metrifonate treatment showed that NTS were still
alive and metabolically functioning but the observation
of the treated parasites via the microscope showed strong
changes on motility and slight morphological changes of
the treated schistosomula. Summarizing, one can state
that a fluorimetric drug assay with S. haematobium NTS
based on resazurin is efficient in detecting severely
damaged respectively dead schistosomula, as already
described for S. mansoni NTS [10]. Unfortunately, the
assay cannot detect drug effects on the motility of the
worms or drugs with slight morphological damages as
demonstrated for oxamniquine and metrifonate.
In our panel of known antischistosomal drugs, metri-
fonate and oxamniquine were included though both
drugs have been replaced by praziquantel and are not
used any longer [6]. Interestingly, we observed a good
in vitro activity of metrifonate, a drug recommended for
treating infections with S. haematobium, on S. mansoni
NTS, which is in line with a previous study using adult
worms [25]. Oxamniquine (used for the treatment of
S. mansoni infections) showed moderate activity against
S. haematobium and S. mansoni NTS, a finding, which is
in contrast to previous results using in vitro cultures
with adult worms [26]. S. haematobium adults were not
affected by oxamniquine, while a moderate activity was
observed against S. mansoni adult worms [15,26]. These
varying drug sensitivities between the schistosomular
and adult stage might possibly be explained with differ-
ences in drug activating enzymes, the main target of
oxamniquine [26].
Conclusions
We have successfully developed an in vitro assay based
on S. haematobium NTS. Using mechanical stress to
transform cercariae into schistosomula instead of
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reduces the use of animals and thus stands in accord-
ance with the 3Rs animal protection principles [9]. It
should be highlighted that although schistosomula have
great advantages when used for viability assays, it is cru-
cial not to neglect adult schistosomes, as previously
mentioned, differing susceptibilities on different parasite
stages are not uncommon. Nonetheless schistosomula
serve as an important starting point for the assessment
of new drug candidates since it allows carrying out
medium to high-throughput screenings.
The resazurin-based assay has proven to be effective,
simple and possibly useful for large screening of drugs
against S. haematobium NTS, though compounds acting
solely on the motility or morphology of the worms
(metrifonate, oxamniquine) might be missed.
However, it must be mentioned that working with
S. haematobium schistosomula respectively, B. truncatus
snails was more time consuming than working with S.
mansoni/ B. glabrata. In addition to that, drug sensi-
tivity screening for both species showed very similar
results. Nevertheless, S. haematobium must not be neg-
lected despite its more laborious work. S. haematobium
infections still occur in most parts of Africa and are a
major problem in developing countries [27]. For this
reason, it is crucial to continue working with both spe-
cies, possibly with S. mansoni first followed by testing of
active compounds against S. haematobium.
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